Search details
1.
Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer.
Mol Ther
; 22(8): 1494-1503, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24791940
2.
MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation.
Invest New Drugs
; 30(6): 2113-20, 2012 Dec.
Article
in English
| MEDLINE | ID: mdl-22127459
3.
p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade.
Cancer Res
; 82(5): 916-928, 2022 03 01.
Article
in English
| MEDLINE | ID: mdl-34965932
4.
IDO1 Inhibition Overcomes Radiation-Induced "Rebound Immune Suppression" by Reducing Numbers of IDO1-Expressing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
Int J Radiat Oncol Biol Phys
; 104(4): 903-912, 2019 07 15.
Article
in English
| MEDLINE | ID: mdl-30905636
5.
130-nm albumin-bound paclitaxel enhances tumor radiocurability and therapeutic gain.
Clin Cancer Res
; 13(6): 1868-74, 2007 Mar 15.
Article
in English
| MEDLINE | ID: mdl-17363543
6.
BAP1 Is a Novel Target in HPV-Negative Head and Neck Cancer.
Clin Cancer Res
; 24(3): 600-607, 2018 02 01.
Article
in English
| MEDLINE | ID: mdl-29113987
7.
Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells.
Cancer Lett
; 431: 54-63, 2018 09 01.
Article
in English
| MEDLINE | ID: mdl-29746927
8.
Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation.
Int J Radiat Oncol Biol Phys
; 67(2): 568-72, 2007 Feb 01.
Article
in English
| MEDLINE | ID: mdl-17236972
9.
Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy.
Cancer Res
; 77(4): 839-850, 2017 02 15.
Article
in English
| MEDLINE | ID: mdl-27821490
10.
Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases.
Radiother Oncol
; 80(2): 185-91, 2006 Aug.
Article
in English
| MEDLINE | ID: mdl-16905211
11.
Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
Clin Cancer Res
; 11(1): 361-9, 2005 Jan 01.
Article
in English
| MEDLINE | ID: mdl-15671567
12.
CpG oligodeoxynucleotide enhances tumor response to radiation.
Cancer Res
; 64(15): 5074-7, 2004 Aug 01.
Article
in English
| MEDLINE | ID: mdl-15289307
13.
PDL1 Regulation by p53 via miR-34.
J Natl Cancer Inst
; 108(1)2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26577528
14.
Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.
Cancer Med
; 4(1): 65-74, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25355701
15.
In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation.
Mol Ther Nucleic Acids
; 4: e270, 2015 Dec 15.
Article
in English
| MEDLINE | ID: mdl-26670277
16.
Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.
Int J Radiat Oncol Biol Phys
; 59(4): 1181-9, 2004 Jul 15.
Article
in English
| MEDLINE | ID: mdl-15234054
17.
Mitigation and treatment of radiation-induced thoracic injury with a cyclooxygenase-2 inhibitor, celecoxib.
Int J Radiat Oncol Biol Phys
; 85(2): 472-6, 2013 Feb 01.
Article
in English
| MEDLINE | ID: mdl-22672748
18.
The impact of timing of EGFR and IGF-1R inhibition for sensitizing head and neck cancer to radiation.
Anticancer Res
; 32(8): 3029-35, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-22843870
19.
Noncovalent assembly of targeted carbon nanovectors enables synergistic drug and radiation cancer therapy in vivo.
ACS Nano
; 6(3): 2497-505, 2012 Mar 27.
Article
in English
| MEDLINE | ID: mdl-22316245
20.
Combination of anti-IGF-1R antibody A12 and ionizing radiation in upper respiratory tract cancers.
Int J Radiat Oncol Biol Phys
; 79(4): 1179-87, 2011 Mar 15.
Article
in English
| MEDLINE | ID: mdl-21129859